M Velia Antonini/X
Oct 24, 2025, 10:16
Marta Velia Antonini: Myth-Busting on Perioperative Autologous Red Blood Cell Salvage
Marta Velia Antonini, Hematologist, Perfusionist ECMO and NRP Specialist and Chair of the Normothermic Regional Perfusion EuroELSO Working Group, shared on X:
“Myth-busting on perioperative autologous red blood cell salvage. Overview of the cell salvage process
- myth: cell-salvaged blood is of poor quality/inferior to allogeneic RBCs: if properly collected/processed, quality of cell salvaged RBCs exceeds allogeneic blood; here some considerations on morphology, oxygen unloading, lifespan, hemolysis, immunological effects
- myth: cell-salvaged blood increases bleeding: residual heparin typically have limited impact… but large-volume acute blood loss still requires factors replacement!
- myth: cell-salvaged blood is not safe in many surgeries: oncologic, obstetric, contaminated surgeries are NOT absolute contraindications… balance/mitigated risks!
- myth: cell-salvaged blood is not cost-effective: generally it is, particularly if employed selectively for high-risk cases
Title: Exploring Myths of Perioperative Autologous Red Blood Cell Salvage
Authors: Kaufman Margit, Jahr Jonathan, Klompas Allan, Perelman Seth, Raphael Jacob, Tan Gee Mei, Frank Steven, Waters Jonathan, Warner Matthew
Open access
Stay informed about latest hemostasis updates with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry
Nov 3, 2025, 09:13
Nov 3, 2025, 08:23
Nov 3, 2025, 07:10
Nov 3, 2025, 04:56